Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20210515051307N1Phase 3Completed
Phase 3, triple-blind trial of autologous adipose stromal vascular fraction in burn scar (2 arms), sponsored by Skin and Stem Cell Research Center. Primary endpoints: Treatment effectiveness, Patient satisfaction and 1 more. Started Aug 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20210515051307N1.